Determining the cell type specific roles of Foxp1 in cortical development.

NIH RePORTER · NIH · F31 · $12,966 · view on reporter.nih.gov ↗

Abstract

Project Summary / Abstract: Approximately, 1 in 59 children in the United States are affected with autism spectrum disorder (ASD). Numerous studies have identified mutations in FOXP1, a gene encoding a transcription factor enriched in the developing and mature neocortex, as causal for ASD. Our group has previously shown that loss of Foxp1 in the mouse cortex leads to reduced cortex size, alterations in cortical lamination, and changes in relative thickness of cortical layers. However, the mechanisms underlying these changes remain unclear. I propose to characterize the developmental requirement of neocortical Foxp1 using time point specific conditional knock-outs of Foxp1 and by measuring transcriptional targets using single nuclei RNA sequencing. I hypothesize that during early embryonic development, Foxp1 facilitates the development of deep layer neurons by repressing factors that specify upper layer neuronal fate. In contrast, I hypothesize that Foxp1 is critical for neuronal identity during late cortical development. The outcome of this work will allow for a better understanding of how Foxp1 governs early cortical development and potential therapeutic windows and molecular pathways for ameliorating loss of function Foxp1 mutations.

Key facts

NIH application ID
9991580
Project number
1F31MH123140-01
Recipient
UT SOUTHWESTERN MEDICAL CENTER
Principal Investigator
Ana Karen Ortiz
Activity code
F31
Funding institute
NIH
Fiscal year
2020
Award amount
$12,966
Award type
1
Project period
2020-06-01 → 2020-08-31